Brief: Dimerix Ltd Posts HY Loss Attributable Of A$6.7 Million
26/02/2024 01:26
Feb 26 (Reuters) - Dimerix Ltd DXB.AX :
* HY REVENUES FROM ORDINARY ACTIVITIES UP 195% TO A$223,527
* HY LOSS ATTRIBUTABLE A$6.7 MILLION
Source text for Eikon: ID:nASX3CzNBk
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions